- Home
- FC vs SGMO Comparison
FC vs SGMO Comparison
Compare FC & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FC | SGMO |
|---|---|---|
| Founded | 1983 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.5M | 141.2M |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FC | SGMO |
|---|---|---|
| Price | $15.22 | $0.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $26.00 | $7.00 |
| AVG Volume (30 Days) | 169.1K | ★ 4.6M |
| Earning Date | 04-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $267,067,000.00 | $36,567,000.00 |
| Revenue This Year | $3.02 | $4.79 |
| Revenue Next Year | $3.66 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 88.60 |
| 52 Week Low | $11.16 | $0.31 |
| 52 Week High | $28.39 | $0.84 |
Technical Indicators
Market Signals| Indicator | FC | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 62.50 | 34.68 |
| Support Level | $14.04 | N/A |
| Resistance Level | $20.33 | $0.55 |
| Average True Range (ATR) | 0.71 | 0.04 |
| MACD | 0.62 | -0.01 |
| Stochastic Oscillator | 87.40 | 6.82 |
Price Performance
Historical ComparisonAbout FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.